| Title | A Phase II, Randomized, Multi-Center, Double-Blind, Comparative Global Study to Determine Efficacy and Safety of Durvalumab in Combination With Olaparib for First-Line Treatment in Platinum-Ineligible Patients with Unresectable Stage IV Urothelial Cancer |
|---|---|
| Disease/Condition | Bladder Cancer,Oncology (Medical/Hematologic),Urologic Oncology (Med Onc),Urologic Diseases,Geriatrics,Neoplasms,Urogenital Neoplasms |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Benjamin Gartrell, MD |
| Contact Name | Gina Aracena |
| Contact Email | gihernan@montefiore.org |
| Protocol Number | 18-06-133-01 |
| Inclusion/Notes | This Information was obtained from ClinicalTrials.gov |
| Status | Active/Enrolling |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |
| Sub-Specialty | Medical and Hematologic Oncology - Bladder |
| Adult, Pediatric, Both | Adult |